Debt-to-equity of PALVELLA THERAPEUTICS, INC. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PALVELLA THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • PALVELLA THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 51%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PALVELLA THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 51% 30 Sep 2025
Q4 2023 1286% +571% +80% 31 Dec 2023
Q3 2023 -2876% -3050% -1758% 30 Sep 2023
Q2 2023 -11918% -12100% -6678% 30 Jun 2023
Q1 2023 14766% +14568% +7364% 31 Mar 2023
Q4 2022 715% +504% +240% 31 Dec 2022
Q3 2022 173% -44% -20% 30 Sep 2022
Q2 2022 181% -27% -13% 30 Jun 2022
Q1 2022 198% +13% +7.2% 31 Mar 2022
Q4 2021 210% +40% +24% 31 Dec 2021
Q3 2021 218% +58% +36% 30 Sep 2021
Q2 2021 208% +11% +5.8% 30 Jun 2021
Q1 2021 185% -78% -30% 31 Mar 2021
Q4 2020 170% -157% -48% 31 Dec 2020
Q3 2020 160% -212% -57% 30 Sep 2020
Q2 2020 196% -100% -34% 30 Jun 2020
Q1 2020 263% +29% +12% 31 Mar 2020
Q4 2019 327% +107% +49% 31 Dec 2019
Q3 2019 372% +120% +47% 30 Sep 2019
Q2 2019 297% -44% -13% 30 Jun 2019
Q1 2019 234% -300% -56% 31 Mar 2019
Q4 2018 220% -533% -71% 31 Dec 2018
Q3 2018 252% -176% -41% 30 Sep 2018
Q2 2018 341% +147% +76% 30 Jun 2018
Q1 2018 533% +466% +696% 31 Mar 2018
Q4 2017 753% +719% +2111% 31 Dec 2017
Q3 2017 428% +401% +1488% 30 Sep 2017
Q2 2017 193% +174% +917% 30 Jun 2017
Q1 2017 67% +49% +269% 31 Mar 2017
Q4 2016 34% +22% +173% 31 Dec 2016
Q3 2016 27% +11% +69% 30 Sep 2016
Q2 2016 19% 30 Jun 2016
Q1 2016 18% 31 Mar 2016
Q4 2015 12% 31 Dec 2015
Q3 2015 16% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.